Table 1.
Participants by Treatment Group and Time Point
| Assessment Time Point Sample Size (n) and Weeks After Baseline (M, SD) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| T1/Baseline | T2 | T3 | T4 | T5 | |||||
| Treatment Group |
N | n | M (SD) | n | M (SD) | n | M (SD) | n | M (SD) |
| ImPACT | 69 | 60 | 6.7 (2.3) | 56 | 14.6 (3.5) | ||||
| PBS/PRT | 33 | 24 | 6.2 (1.8) | 25 | 14.6 (2.6) | 27 | 22.1 (3.3) | ||
| SCI | 89 | 77 | 8.0 (1.3) | 43 | 14.4 (1.4) | 68 | 17.4 (3.6) | ||
| EIBI | 122 | 103 | 6.6 (1.3) | 105 | 12.6 (1.3) | 96 | 18.6 (1.4) | 96 | 25.9 (3.2) |
| PLAYC | 40 | 36 | 6.7 (1.7) | 37 | 13.1 (2.0) | 37 | 19.0 (2.3) | 36 | 26.3 (2.7) |
| Medical | 118 | 76 | 7.3 (1.6) | 75 | 13.1 (1.4) | 82 | 19.5 (1.7) | 84 | 26.6 (4.1) |
| TOTAL | 471 | 376 | 6.9 (1.7) | 341 | 13.7 (2.0) | 310 | 19.3 (2.5) | 216 | 26.3 (3.3) |